New Jersey · Nonprofit
DE-CREASE CANCER A NJ NONPROFIT CORPORATION
DE-CREASE CANCER A NJ NONPROFIT CORPORATION (New Jersey) receives grants from 1 organization whose IRS filings report $68 to it, the largest being AMAZONSMILE FOUNDATION ($68). 1 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- Revenue FY2025
- $0
- Funders on record
- 1
- Grants received
- $68
- Net assets
- $3k
What De-Crease Cancer a Nj Nonprofit Corporation does
Mission
The mission of de-crease cancer is to raise money for cancer research.
As stated on its FY2025 Form 990-EZ.
Program
De-crease cancer received exempt status 9/11/2017 and has not yet initiated any programs.
$1,010 spent100% of program spending
The program described on its FY2025 Form 990-EZ. Program spending in total: $1,010.
The organization over time
Each line starts at 100 in 2017, so what you read is the shape rather than the size: 150 means half as much again as 2017, 50 means half. The number beside each label in the key is where it ended. The shaded band is where the middle 50% of its peers' revenue would sit, given their growth.
Balance sheet
Total assets at each year end, in dollars. The largest one-year move in total assets was 2019 to 2020, from $825 to $3k (+265%).
How it's funded, over time
Each bar is one year's revenue split into where it came from, and every bar is the same height — these are shares, not amounts, so a year that raised twice as much looks the same size. Hover a bar for the split.
100% of DE-CREASE CANCER A NJ NONPROFIT CORPORATION’s revenue is contributions — more reliant on donations than three-quarters of its peers (100% for the typical peer).
Surplus & reserves
Operating surplus or deficit each year, and months of liquidity in hand. 3 of the last 9 reported years ran a deficit.
Who funds it, year by year
2021 → 2023: the base held at 1 funder, grant income fell $29 → $26.
1 of 1 of your funders are donor-advised or pass-through sponsors (tagged DAF) — 100% of grant dollars received. That money is really individual donors directing a sponsor; the institutions to cultivate are the non-DAF funders.
From the IRS filings of DE-CREASE CANCER A NJ NONPROFIT CORPORATION’s funders (the co-funder graph). Association, not causation. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Where its funders are
100% of DE-CREASE CANCER A NJ NONPROFIT CORPORATION's grant income arrives through donor-advised or pass-through sponsors, whose addresses record where the money is held rather than where the donor is. Too little is directly attributable to place on a map.
Funder states come from each funder’s own filing. $68 arriving through sponsors registered in 1 state is excluded from the map and the split above: a sponsor holds money on a donor’s behalf, so its registered address would place those dollars somewhere no donor need ever have been. Trends are read to FY2023, the last fiscal year that has finished arriving. FY2024–FY2026 are still being filed and are shown unshaded; they do not move any figure on this page.
Against its field
DE-CREASE CANCER A NJ NONPROFIT CORPORATION's revenue fell 100% between 2017 and 2025.
this organization peer median middle 50% of peers· 6,360 health nonprofits under $100k, FY2025
Organizations like DE-CREASE CANCER A NJ NONPROFIT CORPORATION
Organizations whose mission and program text most resemble this one, by semantic similarity over every organization in the US filings — the closest peers, and often the clearest route to shared or prospective funders.
In New Jersey
Nationally
Read directly from this organization’s own Form 990, as neutral context.
Public support
0%
Share of support from the public (Schedule A) — the basis for its public-charity status.
Screen this organization
A dated, signed PDF of the compliance screen for DE-CREASE CANCER A NJ NONPROFIT CORPORATION: IRS status (Business Master File, Publication 78, auto-revocation), the OFAC sanctions lists, the Internal Revenue Bulletin, and California registration, with the Rev. Proc. 2018-32 §8.01 reliance elements stated element by element. Generated from the current files at the moment you download it.
Screens are triage, not determinations; a source that cannot be read reports not screened, never clear. Screen this nonprofit · How the screen works · on the API as GET /api/screening/{ein}?format=pdf
Questions and answers
- Who funds DE-CREASE CANCER A NJ NONPROFIT CORPORATION?
- DE-CREASE CANCER A NJ NONPROFIT CORPORATION (New Jersey) receives grants from 1 organization whose IRS filings report $68 to it, the largest being AMAZONSMILE FOUNDATION ($68). 1 of them have funded it in more than one year, and 100% of the money arrives through donor-advised or pass-through sponsors rather than from an institution directly.
- How many funders does DE-CREASE CANCER A NJ NONPROFIT CORPORATION have?
- IRS filings report 1 organization giving $68 in grants to DE-CREASE CANCER A NJ NONPROFIT CORPORATION, 1 of which have funded it in more than one year.
- Who is the largest funder of DE-CREASE CANCER A NJ NONPROFIT CORPORATION?
- AMAZONSMILE FOUNDATION is the largest funder on record, with $68 in grants. The full list of funders is on this page.
- How can an organization like DE-CREASE CANCER A NJ NONPROFIT CORPORATION find more funders?
- Start with the funders already giving here, then look at the foundations that back similar organizations in New Jersey. The funding by cause and by state pages list the largest funders for a given area and how to approach them.
Play a game about who funds De-Crease Cancer a Nj Nonprofit →
These figures are read directly from IRS Form 990 / 990-PF e-file XML: this organization’s own return for FY2025 (financials across 2017–2025), and the filings of 1 funders that report grants to it. “On record” means captured in the filings we have parsed — a funder that does not e-file, or whose grant detail is not itemized, will not appear. Filings run roughly 12–24 months behind. Trends on this page end at FY2023, the last fiscal year that has finished arriving; later years are shown and marked, and move no figure. Data on this page was exported October 14, 2026. What this page cannot tell you · view filing